We are live on ! Find out more
DCM

DAFNA Capital Management Portfolio holdings

AUM $440M
1-Year Est. Return 109.12%
This Fund
S&P 500
This Quarter Est. Return
+19.58%
1 Year Est. Return
+109.12%
3 Year Est. Return
+239.59%
5 Year Est. Return
+227.89%
10 Year Est. Return
+3,611.91%
AUM
$161M
AUM Growth
+$20.9M
Cap. Flow
-$8.51M
Cap. Flow %
-5.29%
Top 10 Hldgs %
48.45%
Holding
88
New
12
Increased
11
Reduced
19
Closed
14

Top Buys

Rank Stock Value
1
DXCM icon
DexCom
DXCM
+$4.07M
2
BCRX icon
BioCryst Pharmaceuticals
BCRX
+$3.08M
3
CBAY
Cymabay Therapeutics
CBAY
+$2.81M
4
ACHN
Achillion Pharmaceuticals
ACHN
+$2.01M
5
TVRD
Tvardi Therapeutics
TVRD
+$1.31M

Top Sells

Rank Stock Value
1
LOXO
Loxo Oncology, Inc
LOXO
+$3.22M
2
SPNC
Spectranetics Corp
SPNC
+$2.15M
3
SGMO
SANGAMO THERAPEUTICS INC
SGMO
+$1.98M
4
CLLS
Cellectis
CLLS
+$1.97M
5
IMMU
Immunomedics Inc
IMMU
+$1.77M

Sector Composition

Rank Sector Weight
1 Healthcare 80.09%
Name Market Value Portfolio Weight Shares or Principal Change
in Stake 		Capital Flow
ARNA
76
DELISTED
Arena Pharmaceuticals Inc
ARNA
– –
-15,550
Closed -$262K
TRIL
77
DELISTED
Trillium Therapeutics Inc.
TRIL
– –
-20,000
Closed -$88K
ARRY
78
DELISTED
Array Biopharma Inc
ARRY
– –
-20,000
Closed -$167K
SPNC
79
DELISTED
Spectranetics Corp
SPNC
– –
-55,896
Closed -$2.15M
ELOS
80
DELISTED
Syneron Medical Ltd
ELOS
– –
-85,947
Closed -$941K
1 2 3
4

Similar funds

CDMG
Creek Drive Management Group San Francisco, California $439M AUM
STCG
Speece Thorson Capital Group Minnetonka, Minnesota $439M AUM 10.15% 1-Year Est. Return
SCP
SailingStone Capital Partners Houston, Texas $440M AUM 127.21% 1-Year Est. Return
CAAM
Cape Ann Asset Management London, United Kingdom $440M AUM 96.23% 1-Year Est. Return
HCM
Harvey Capital Management Palm Beach, Florida $439M AUM 37.68% 1-Year Est. Return
CPW
Cove Private Wealth Oyster Bay Cove, New York $440M AUM 27.56% 1-Year Est. Return
BOA
Birnam Oak Advisors New York $441M AUM 37.12% 1-Year Est. Return
DWML
Decker Wealth Management LLC Nashville, Tennessee $441M AUM

DAFNA Capital Management's Q3 2017 Portfolio in Review

As of Q3 2017, DAFNA Capital Management held 88 positions worth $161M, up 15% from $140M the previous quarter. Its ten largest holdings account for 48% of the portfolio.

DAFNA Capital Management withdrew a net $8.51M in Q3 2017, closing 14 positions and reducing 19 holdings. Its most notable exit was Spectranetics Corp, an estimated $2.15M position sold in full.

By sector, the portfolio is most concentrated in Healthcare at 80% of assets, up from 80% a quarter earlier.

Against the trend, DAFNA Capital Management opened a new position in DexCom worth $2.81M.

  • DAFNA Capital Management's largest Q3 2017 buy was DexCom: 230,000 shares worth $2.81M.
  • DAFNA Capital Management added most to BioCryst Pharmaceuticals in Q3 2017, an estimated $3.08M increase.
  • DAFNA Capital Management's biggest Q3 2017 reduction was Loxo Oncology, Inc, cutting an estimated $3.22M.
  • DAFNA Capital Management fully exited Spectranetics Corp in Q3 2017, selling an estimated $2.15M.
  • DAFNA Capital Management's ten largest holdings make up 48% of its $161M portfolio in Q3 2017.
  • DAFNA Capital Management opened 12 new positions and closed 14 in Q3 2017.
  • DAFNA Capital Management's portfolio value rose 15% quarter-over-quarter to $161M.

Based on DAFNA Capital Management's 13F filing for Q3 2017, filed 14 Nov 2017.